BLEEDING RISK WITH APIXABAN VS. RIVAROXABAN IN ACUTE VENOUS THROMBOEMBOLISM
Same clinical topic · Hematology
BLEEDING RISK WITH APIXABAN VS. RIVAROXABAN IN ACUTE VENOUS THROMBOEMBOLISM
Same clinical topic · Hematology
ACUTE MYELOID LEUKEMIA: 2025 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION, AND MANAGEMENT
Same clinical topic · Hematology
Myeloproliferative Neoplasms
Same clinical topic · Hematology
MASTOCYTOSIS
Same clinical topic · Hematology
MYELODYSPLASTIC SYNDROMES: 2023 UPDATE ON DIAGNOSIS, RISK-STRATIFICATION, AND MANAGEMENT
Same clinical topic · Hematology
PERIPHERAL T-CELL LYMPHOMAS
Same clinical topic · Hematology
UPDATE ON TRANSFUSION-RELATED ACUTE LUNG INJURY: AN OVERVIEW OF ITS PATHOGENESIS AND MANAGEMENT
Same clinical topic · Hematology
COMPARISON OF THE INTERNATIONAL CONSENSUS AND 5TH WHO EDITION CLASSIFICATIONS OF ADULT MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA
Same clinical topic · Hematology